LEARN MORE

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.

LEARN MORE

Events

Cantor Fitzgerald's Global Healthcare Conference

Click for Additional Information

9/27/17

Child Neurology Society

10/4/17 - 10/7/17

More Events >

Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >

Follow Us on Twitter

Marinus Pharma's Twitter avatar
Marinus Pharma
@MarinusPharma

Marinus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference. Press release:… t.co/IUl7dsdLMq